Literature DB >> 3742674

Antibodies to liposomes, phospholipids and phosphate esters.

C R Alving.   

Abstract

Polyclonal and monoclonal antibodies to liposomes having various phospholipid compositions have been produced. Binding of the anti-lipid bilayer antibodies is influenced both by the chemical composition and the physical state of the liposomal lipids. The antibodies to liposomes have a 'subsite' in the binding site that recognizes small soluble phosphorylated haptens such as nucleotides (e.g., ATP). The capacity of anti-liposome antibodies to bind to phosphate is also shared by antibodies to numerous other substances, including lipid A from Gram-negative bacterial lipopolysaccharide, cardiolipin, DNA, polynucleotides, and lipoteichoic acids from Gram-positive bacteria. Because of similarities of chemical structures between all of these molecules widespread immunological cross-reactivities are observed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742674     DOI: 10.1016/0009-3084(86)90075-7

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  14 in total

1.  Lupus anticoagulant activities of murine monoclonal antibodies to liposomal phosphatidylinositol phosphate.

Authors:  B M Alving; B Banerji; W E Fogler; C R Alving
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

Review 2.  What else can the immune system recognize?

Authors:  D Izhaky; I Pecht
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

3.  Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.

Authors:  S Hörkkö; E Miller; E Dudl; P Reaven; L K Curtiss; N J Zvaifler; R Terkeltaub; S S Pierangeli; D W Branch; W Palinski; J L Witztum
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

4.  Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo.

Authors:  J Rauch; A S Janoff
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

5.  Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.

Authors:  M A Khamashta; E N Harris; A E Gharavi; G Derue; A Gil; J J Vázquez; G R Hughes
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

6.  Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens.

Authors:  C A Bate; J Taverne; J H Playfair
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

7.  Fatty acid chain is a critical epitope for antiphospholipid antibody.

Authors:  R A Levy; A E Gharavi; L R Sammaritano; L Habina; M D Lockshin
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

8.  Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H).

Authors:  A E Gharavi; L R Sammaritano; J Wen; K B Elkon
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 9.  Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future.

Authors:  Anna N Ilinskaya; Marina A Dobrovolskaia
Journal:  Toxicol Appl Pharmacol       Date:  2016-01-07       Impact factor: 4.219

10.  Antibodies to cholesterol.

Authors:  G M Swartz; M K Gentry; L M Amende; E J Blanchette-Mackie; C R Alving
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.